Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Julia Blau"'
Autor:
Rachel Aldred
Publikováno v:
Critical Social Policy. 29:166-168
Autor:
Marcus A. Chilaka
Publikováno v:
The International Journal of Health Planning and Management. 24:185-186
Autor:
Chilaka, Marcus A1
Publikováno v:
International Journal of Health Planning & Management. Apr2009, Vol. 24 Issue 2, p185-186. 2p.
Autor:
Bernard Kaić, B. Mounaud, Andrew Clark, Céline Hoestlandt, V. Višekruna Vučina, V. Stamenić, N. Kožnjak, S. Kurečić Filipović, Julia Blau
Publikováno v:
Vaccine. 33:A209-A218
Objective Pneumococcus is a known cause of meningitis, pneumonia, sepsis, and acute otitis media in children and adults globally. Two new vaccines for children have the potential to prevent illness, disability, and death, but these vaccines are expen
Autor:
Andrew Clark, M. Shakhnazarova, R. Chlikadze, Céline Hoestlandt, M. Kherkheulidze, K. Goginashvili, T. Dolakidze, T. Komakhidze, N. Kopaleishvili, Julia Blau
Publikováno v:
Vaccine. 33:A219-A226
Objective Financial support from the Global Alliance for Vaccines and Immunization (GAVI) to introduce the 10-valent pneumococcal conjugate vaccine (PCV10) into the routine childhood immunization schedule in Georgia is ending in 2015. As a result, th
Autor:
Céline Hoestlandt, Andrew Clark, L Baxter, Julia Blau, Liudmila Mosina, Bérénice Mounaud, Ana Gabriela Felix Garcia
Publikováno v:
Vaccine. 33:A34-A39
Background For many years, low- and middle-income countries have made efforts to strengthen national decision-making on immunization. The Pan American Health Organization (PAHO) ProVac Initiative was established to help expedite the use of evidence-b
Autor:
Philippe Duclos, Marine Clementz, Barbara Jauregui, Julia Blau, Kamel Senouci, Nihal Abeysinghe, Yoshihiro Takashima, Cara Bess Janusz, Richard Mihigo, Nahad Sadr-Azodi, Niyazi Cakmak, Liudmila Mosina
Publikováno v:
Vaccine. 31:2653-2657
A National Immunization Technical Advisory Group (NITAG) is an expert advisory committee that provides evidence-based recommendations to the Ministry of Health (MoH) to guide immunization programs and policies. The World Health Organization (WHO), th
Autor:
Brad D. Gessner, Philippe Stoeckel, John D. Clemens, Julia Blau, Papa Coumba Faye, Alfred Da Silva, Kamel Senouci, Batmunkh Nyambat, Lara Gautier, Michael O. Favorov
Publikováno v:
Vaccine. 28:A26-A30
Multiple health priorities, limited human resources and logistical capacities, as well as expensive vaccines with limited funds available increase the need for evidence-based decision making in immunization programs. The aim of the Supporting Indepen
Autor:
L Baxter, Raymond Hutubessy, Cara Bess Janusz, Aline Munier, Rana A. Hajjeh, Jon Kim Andrus, Deborah Atherly, Ana Gabriela Felix Garcia, Benjamin A. Lopman, Barbara Jauregui, Mercy Mvundura, Andrew Clark, Ciro de Quadros, Julia Blau
Publikováno v:
Jauregui, B, Felix Garcia, A G, Bess Janusz, C, Blau, J, Munier, A, Atherly, D, Mvundura, M, Hajjeh, R, Lopman, B, Clark, A D, Baxter, L, Hutubessy, R, de Quadros, C & Andrus, J K 2015, ' Evidence-based decision-making for vaccine introductions : overview of the ProVac International Working Group's experience ', Vaccine, vol. 33, no. Supplement 1, pp. A28-A33 . https://doi.org/10.1016/j.vaccine.2014.10.090
Introduction: Pan American Health Organization's (PAHO) ProVac Initiative aims to strengthen countries' technical capacity to make evidence-based immunization policy. With financial support from the Bill and Melinda Gates Foundation, PAHO established
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c987e1660ac0fcfdda89d59412fbc226
https://researchportal.port.ac.uk/portal/en/publications/evidencebased-decisionmaking-for-vaccine-introductions(280add77-4cc5-4678-b616-8f34c58dcf0a).html
https://researchportal.port.ac.uk/portal/en/publications/evidencebased-decisionmaking-for-vaccine-introductions(280add77-4cc5-4678-b616-8f34c58dcf0a).html
Autor:
Andrew Clark, Erida Nelaj, Julia Blau, Ana Gabriela Felix Garcia, Carlos Lara, Silvia Bino, Céline Hoestlandt, Albana Ahmeti, Iria Preza, Artan Simaku
Publikováno v:
Vaccine. 33
Background Rotavirus vaccines have been introduced in several European countries but can represent a considerable cost, particularly for countries that do not qualify for any external financial support. This study aimed to evaluate the cost-effective